乳房缩小成形术中的抗生素预防:一项随机对照试验的研究方案
本研究为双盲随机临床试验,纳入124例乳房肥大患者,分为抗生素组(n=62)和安慰剂组(n=62),评估术后口服头孢氨苄与安慰剂对乳房缩小成形术后手术部位感染(SSI)发生率的影响。所有患者接受同一手术团队实施的乳房缩小成形术,术后随访30天,由对分组不知情的单一外科医生依据美国疾病控制与预防中心定义评估SSI。
要点
- 双盲随机对照试验,纳入124例乳房肥大患者,抗生素组与安慰剂组各62例。
- 术后口服头孢氨苄或安慰剂,每6小时一次,持续7天。
- 主要结局为术后30天内依据美国疾病控制与预防中心定义评估的SSI发生率。
核心结论
- 本研究旨在评估术后抗生素治疗对乳房缩小成形术后手术部位感染发生率的影响。
研究设计与样本
- 双盲随机临床试验,纳入124例乳房肥大患者,分配至抗生素组(n=62)和安慰剂组(n=62)。
- 所有患者由同一手术团队实施乳房缩小成形术,采用上内侧蒂技术提升乳头乳晕复合体。
- 患者麻醉诱导时静脉给予抗生素,住院24小时期间每6小时一次;出院时领取编号包装的头孢氨苄或安慰剂胶囊,每6小时一次,持续7天。
- 手术团队和患者均不知晓胶囊内容物。
- 出院后30天内由对治疗分组不知情的单一外科医生每周监测一次SSI发生情况。
关键数值与推荐
- SSI评估依据美国疾病控制与预防中心采用的定义。
- 术后抗生素每6小时一次,持续7天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,由于SSI危险因素多样且病例研究有限,关于抗生素对乳房缩小成形术后SSI发生影响的结论可能存在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of antibiotics in surgical procedures where the risk of surgical site infection (SSI) is low remains uncertain. There is, to date, no evidence to justify the routine use of antibiotics in postoperative reduction mammaplasty. The aim of this study is to evaluate the effect of postoperative antibiotic treatment on the occurrence of SSI after breast reduction surgery. METHODS: This is a double-blind randomized clinical trial with 124 breast hypertrophy patients allocated to two treatment groups: antibiotic (n = 62) and placebo (n = 62). All patients will undergo reduction mammoplasty, performed by the same surgical team. The surgeons will raise the nipple-areola complex by the superomedial pedicle technique. The patients will receive antibiotics intravenously during anesthetic induction and every 6 hours thereafter during their 24-hour hospital stay. During discharge from the hospital, each patient will receive a numbered package containing either cephalexin or placebo capsules and will be directed to take one capsule every 6 hours for 7 days. Neither the surgery team nor the patients will know the contents of the capsules. Patients will be monitored for the occurrence of SSI once weekly during the first 30 days following hospital discharge by a single surgeon who is blinded to their treatment group. SSI will be evaluated based on the definition adopted by the Centers for Disease Control and Prevention. DISCUSSION: Due to the variety of risk factors for SSI and limited case studies, conclusions regarding the effect of antibiotics on the occurrence of SSIs following reduction mammaplasty are potentially biased. In recent studies, perioperative antibiotic prophylaxis was effective in preventing infection and is therefore recommended in clinical practice. However, antibiotic use in the postoperative period still remains controversial. TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT02569866 . Registered on 4 October 2015.
引用
- Garcia ES, Veiga DF, Veiga-Filho J, et al. Antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial. Trials. 2016. PMID: 27899130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。